Implications for immunosurveillance of altered HLA class I phenotypes in human tumours (Q41370602)

30 September 2017

1 reference

title

Implications for immunosurveillance of altered HLA class I phenotypes in human tumours (English)

1 reference

30 September 2017

1 reference

Garrido F

1

1 reference

30 September 2017

Ruiz-Cabello F

2

1 reference

30 September 2017

Cabrera T

3

1 reference

30 September 2017

Pérez-Villar JJ

4

1 reference

30 September 2017

López-Botet M

5

1 reference

30 September 2017

Duggan-Keen M

6

1 reference

30 September 2017

Stern PL

7

1 reference

30 September 2017

1 February 1997

1 reference

30 September 2017

1 reference

30 September 2017

18

1 reference

30 September 2017

89-95

1 reference

30 September 2017

2

1 reference

Tumor regression responses in melanoma patients treated with a peptide encoded by gene MAGE-3

30 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2896%2910075-X

7 January 2021

Active specific immunotherapy of melanoma with allogeneic cell lysates. Rationale, results, and possible mechanisms of action

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2896%2910075-X

7 January 2021

A recombinant vaccinia virus encoding human papillomavirus types 16 and 18, E6 and E7 proteins as immunotherapy for cervical cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2896%2910075-X

7 January 2021

Natural history of HLA expression during tumour development.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2896%2910075-X

7 January 2021

The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2896%2910075-X

7 January 2021

Receptors for HLA class-I molecules in human natural killer cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2896%2910075-X

7 January 2021

Inhibitory MHC class I receptors on NK cells and T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2896%2910075-X

7 January 2021

Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2896%2910075-X

7 January 2021

Further evidence for depression of H-2 and Ia-like specificities of foreign haplotypes in mouse tumour cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2896%2910075-X

7 January 2021

Lack of HLA class I antigen expression by cultured melanoma cells FO-1 due to a defect in B2m gene expression

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2896%2910075-X

7 January 2021

Loss of transporter protein, encoded by the TAP-1 gene, is highly correlated with loss of HLA expression in cervical carcinomas.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2896%2910075-X

7 January 2021

Repression of class I H-2K, H-2D antigens on GR9 methylcholanthrene-induced tumour cell clones is related to the level of DNA methylation

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2896%2910075-X

7 January 2021

The HLA-A,B,C genotype of the class I negative cell line Daudi reveals novel HLA-A and -B alleles

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2896%2910075-X

7 January 2021

Loss of HLA class I antigens by melanoma cells: molecular mechanisms, functional significance and clinical relevance

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2896%2910075-X

7 January 2021

Mechanisms of loss of HLA class I expression on colorectal tumor cells

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2896%2910075-X

7 January 2021

Loss of an HLA haplotype in pancreas cancer tissue and its corresponding tumor derived cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2896%2910075-X

7 January 2021

Tumor antigens recognized by T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2896%2910075-X

7 January 2021

Transcriptional suppression of HLA-B expression by c-Myc is mediated through the core promoter elements

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2896%2910075-X

7 January 2021

Differences in the antigens recognized by cytolytic T cells on two successive metastases of a melanoma patient are consistent with immune selection

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2896%2910075-X

7 January 2021

Differences in MHC and TAP-1 expression in cervical cancer lymph node metastases as compared with the primary tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2896%2910075-X

7 January 2021

The life span of major histocompatibility complex-peptide complexes influences the efficiency of presentation and immunogenicity of two class I-restricted cytotoxic T lymphocyte epitopes in the Epstein-Barr virus nuclear antigen 4

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2896%2910075-X

7 January 2021

Use of a selectable marker regulated by alpha interferon to obtain mutations in the signaling pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2896%2910075-X

7 January 2021

Characterization of a gastric tumor cell line defective in MHC class I inducibility by both alpha- and gamma-interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2896%2910075-X

7 January 2021

Molecular clones of the p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra- and intracellular domains

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2896%2910075-X

7 January 2021

Cloning of immunoglobulin-superfamily members associated with HLA-C and HLA-B recognition by human natural killer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2896%2910075-X

7 January 2021

The natural killer cell receptor specific for HLA-A allotypes: a novel member of the p58/p70 family of inhibitory receptors that is characterized by three immunoglobulin-like domains and is expressed as a 140-kD disulphide-linked dimer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2896%2910075-X

7 January 2021

Natural killer cell receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2896%2910075-X

7 January 2021

CD94 and a novel associated protein (94AP) form a NK cell receptor involved in the recognition of HLA-A, HLA-B, and HLA-C allotypes

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2896%2910075-X

7 January 2021

CD94 functions as a natural killer cell inhibitory receptor for different HLA class I alleles: identification of the inhibitory form of CD94 by the use of novel monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2896%2910075-X

7 January 2021

NK-cell receptors and recognition of MHC class I molecules

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2896%2910075-X

7 January 2021

The enigma of the natural killer cell

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2896%2910075-X

7 January 2021

In search of the 'missing self': MHC molecules and NK cell recognition

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2896%2910075-X

7 January 2021

A weakly tumorigenic phenotype with high MHC class-I expression is associated with high metastatic potential after surgical removal of the primary murine fibrosarcoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2896%2910075-X

7 January 2021

Peptide specificity in the recognition of MHC class I by natural killer cell clones

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2896%2910075-X

7 January 2021

Frequency of down-regulation of individual HLA-A and -B alleles in cervical carcinomas in relation to TAP-1 expression

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2896%2910075-X

7 January 2021

Relative roles of natural killer- and T cell-mediated anti-leukemia effects in chronic myelogenous leukemia patients treated with interferon-alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2896%2910075-X

7 January 2021

The role of Ly49A and 5E6(Ly49C) molecules in hybrid resistance mediated by murine natural killer cells against normal T cell blasts

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2896%2910075-X

7 January 2021

Heterogeneous phenotypes of expression of the NKB1 natural killer cell class I receptor among individuals of different human histocompatibility leukocyte antigens types appear genetically regulated, but not linked to major histocompatibililty comple

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2896%2910075-X

7 January 2021

The association of an HPV16 oncogene variant with HLA-B7 has implications for vaccine design in cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2896%2910075-X

7 January 2021

Immunotherapy of human colon cancer by antibody-targeted superantigens

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2896%2910075-X

7 January 2021

High frequency of altered HLA class I phenotypes in invasive breast carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2896%2910075-X

7 January 2021

Lack of MHC class I antigens and tumour aggressiveness of the squamous cell carcinoma of the larynx

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2896%2910075-X

7 January 2021

Loss of HLA class I expression in prostate cancer: implications for immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2896%2910075-X

7 January 2021

10.1016/S0167-5699(96)10075-X

Identifiers

DOI

1 reference

30 September 2017

1 reference